Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MPS PharmaaBOM:531686 11 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates BOM:531686 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, MPS Pharmaa ranks worse than 108695.54% on this metric.
The historical rank and industry rank for MPS Pharmaa's Days Inventory or its related term are showing as below:
During the past 13 years, MPS Pharmaa's highest Days Inventory was 260381.88. The lowest was 88.32. And the median was 3979.71.
BOM:531686's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 165.11 * Ranked among companies with meaningful Days Inventory only.
MPS Pharmaa's Days Inventory
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
MPS Pharmaa's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MPS Pharmaa (BOM:531686) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MPS Pharmaa's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MPS Pharmaa's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MPS Pharmaa Days Inventory Related Terms
MPS Pharmaa Days Inventory Historical Data
* Premium members only.
The historical data trend for MPS Pharmaa's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MPS Pharmaa Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's Days Inventory distribution charts can be found below:
* The bar in red indicates where MPS Pharmaa's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MPS Pharmaa (BOM:531686) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MPS Pharmaa and its competitors. Over the past decade, MPS Pharmaa's Days Inventory has ranged from 88.32 to 260,381.88. According to the industry distribution chart, MPS Pharmaa ranks #999999 out of 920 companies in the Drug Manufacturers industry.
Is MPS Pharmaa's Days Inventory too high?
MPS Pharmaa's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 88.32 to a high of 260,381.88. Based on the distribution chart, MPS Pharmaa ranks #999999 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, MPS Pharmaa has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does MPS Pharmaa's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, MPS Pharmaa ranks #999999 out of 920 companies for Days Inventory. This places MPS Pharmaa in the lower half of its industry. The industry median Days Inventory is 165.11. Historically, MPS Pharmaa's own Days Inventory has ranged from 88.32 to 260,381.88 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.11, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MPS Pharmaa and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPS Pharmaa's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPS Pharmaa stock overvalued right now?
MPS Pharmaa (BOM:531686) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. MPS Pharmaa's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MPS Pharmaa (BOM:531686), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and exporting Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory, and antibacterials & antibiotics. Its products include Wibatol, Robial, Twosum, Arfa Gel, and others.
11GF Score
Get the complete analysis for BOM:531686
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531686 has been successfully added to your 
